Selective FLCN Inhibition Drives Lipid Secretion and Protects Mice From MAFLD
Selective suppression of the FLCN/TFE3 branch of mTORC1 signaling drives VLDL-TG secretion and protects mice from metabolic fatty liver disease.
Selective suppression of the FLCN/TFE3 branch of mTORC1 signaling drives VLDL-TG secretion and protects mice from metabolic fatty liver disease.
Researchers identified that ACE2-enriched exosomes from small intestinal endocrine cells travel to the liver and reduce inflammation and fibrosis in ...
A phase two clinical trial in Japan found the experimental peptide redasemtide was well tolerated and associated with early reductions ...
Researchers found CASP4 expression increased with fibrosis severity in steatotic liver disease and showed that targeting CASP4 with siRNA attenuated ...
Genetic and pharmacological inactivation of soluble epoxide hydrolase preserved anti-inflammatory epoxy fatty acids and reduced liver injury, inflammation, and fibrosis ...
A comprehensive scientific review reveals that cellular senescence in metabolic dysfunction-associated steatotic liver disease operates through multicellular communication loops connecting ...
A systematic bibliometric analysis of 1,157 publications confirms a global shift in gut probiotic research from broad dysbiosis associations toward ...
A cross-sectional study in China links biopsy-defined metabolic dysfunction-associated steatotic liver disease with lower bone mineral density in adults aged ...
Genetic deletion and pharmacological inhibition of phosphodiesterase 3B protected intestinal barrier integrity and suppressed hepatic inflammation and fibrosis in mouse ...
Researchers have identified FADS1 as a candidate shared biomarker linking metabolic dysfunction-associated steatohepatitis to early-onset colorectal cancer through machine learning ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine